Julen
Oyarzabal Santamarina
Forscher bis um 2018
Universidad de Salamanca
Salamanca, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad de Salamanca (2)
2021
-
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Hepatology, Vol. 73, Núm. 6, pp. 2380-2396
2020
-
Dual pharmacological targeting of hdacs and pde5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis
Cancers, Vol. 12, Núm. 12, pp. 1-27